This paradoxical phenomenon could be explained by the following researches: on the one hand, cyclooxygenase-2 (COX-2) inhibitors (non-steroidal anti-inflammatory drugs) could significantly impair fracture healing (37); on the other hand, patients with diabetes mellitus (systematic inflammation) also have impaired fracture healing (38). The gene discussed is PTGS2; the disease is diabetes mellitus.